- Home
- PROP vs IXHL Comparison
PROP vs IXHL Comparison
Compare PROP & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | PROP | IXHL |
|---|---|---|
| Founded | 2001 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.6M | 97.6M |
| IPO Year | 2008 | 2024 |
Fundamental Metrics
Financial Performance| Metric | PROP | IXHL |
|---|---|---|
| Price | $1.75 | $0.27 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 4.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.95 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,939,000.00 | $12,000.00 |
| Revenue This Year | $3,546.93 | N/A |
| Revenue Next Year | $84.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 413.59 | N/A |
| 52 Week Low | $1.57 | $0.11 |
| 52 Week High | $7.77 | $1.66 |
Technical Indicators
Market Signals| Indicator | PROP | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 39.03 |
| Support Level | $1.66 | $0.25 |
| Resistance Level | $1.93 | $0.42 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 27.16 | 41.37 |
Price Performance
Historical ComparisonAbout PROP Prairie Operating Co.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.